Detalles de la búsqueda
1.
Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers.
Eur J Nucl Med Mol Imaging
; 51(1): 233-244, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642703
2.
Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study.
Pharmaceuticals (Basel)
; 17(3)2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543061
3.
Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer.
Pharmaceuticals (Basel)
; 16(4)2023 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37111277
4.
Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer.
Thyroid
; 33(8): 974-982, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171126
5.
[111In]In/[177Lu]Lu-AAZTA5-LM4 SST2R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results.
Pharmaceutics
; 15(3)2023 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36986637
Resultados
1 -
5
de 5
1
Próxima >
>>